2019 Agenda

May 17, 2019 | Hyatt Regency Dallas

7:30 - 8:00 AM

Attendee Check-in & Networking Breakfast

8:00 - 8:10 AM

Welcome Remarks

Polly Parsons, MD, ATSF, President - American Thoracic Society DOWNLOAD PRESENTATION
Tom Salemi, Content Director - Healthegy DOWNLOAD PRESENTATION

8:10 - 8:20 AM

The RIS Co-Chair Respiratory Report

Presented By:
Cecilia Gonzalo, Partner - Oberland Capital
Timothy Watkins, MD, MSc, Executive Director, Clinical Research, Respiratory Disease Area Lead, Inflammation/Respiratory Therapeutic Area - Gilead Sciences

8:20 - 8:45 AM

How Innovation Impacts Patient Perspectives

Participants:
Donna Appell, RN, Executive Director - Hermansky-Pudlak Syndrome Network
Gregory Porta, Director & Founder - chILD Foundation
Ginger Spitzer, Executive Director - Foundation for Sarcoidosis Research
Tonya Winders, MBA, President & CEO - Allergy & Asthma Network

Co-Moderated By:
Theodore Reiss, MD, MBE, Corporate VP, Head of I&I Clinical R&D - Celgene Corporation
Timothy Watkins, MD, MSc,  Executive Director, Clinical Research, Respiratory Disease Area Lead, Inflammation/Respiratory Therapeutic Area - Gilead Sciences

8:46 - 9:16 AM

RIS Innovation Showcase

8:46 - 8:52 AM  | Altavant Sciences | Lyn Baranowski, COO DOWNLOAD PRESENTATION
8:52 - 8:58 AM  | AVISA | David Joseph, President & CEO DOWNLOAD PRESENTATION
8:58 - 9:04 AM | Pharmosa Biopharm | Pei Kan, President DOWNLOAD PRESENTATION
9:04 - 9:10 AM  | Pulmocide | Pete Strong, CSO DOWNLOAD PRESENTATION
9:10 - 9:16 AM  | Savara | John Lord, PhD, SVP & Head of R&D DOWNLOAD PRESENTATION

9:16 - 10:25 AM

Where are the Opportunities, Challenges in Airway Disease

A. Market Overview DOWNLOAD PRESENTATION

Presented By:
Bruce Levy, MD, Chief, Division of Pulmonary and Critical Care Medicine - Brigham and Women’s Hospital

B. Company Presentations

9:23 - 9:29 AM  | Amiko | Martijn Grinovero, CCO DOWNLOAD PRESENTATION
9:29 - 9:35 AM  | HCmed Innovations | Jason Cheng, Founder & CEO DOWNLOAD PRESENTATION
9:35 - 9:41 AM | Sommetrics | Richard Rose, MD, President & CEO DOWNLOAD PRESENTATION
9:41 - 9:47 AM  | Eldec Pharmaceuticals | Robert Tarran, PhD, Founder & CSO

C. Panel Discussion

Participants:
Benjamin Kramer, MD, VP, Immunology & Ophthalmology, US Medical Affairs - Genentech
Heidi Mansour, PhD, RPh, Associate Professor - The University of Arizona Colleges of Pharmacy & Medicine
Jonathan Phillips, Principal Scientist - Amgen
Colin Reisner, MD, SVP & Head of Late RIA, R&D BioPharmaceuticals - AstraZeneca
Marcella Ruddy, MD, VP, Clinical Development Respiratory & Inflammation - Regeneron

Moderated By:
Bruce Levy, MD, Chief, Division of Pulmonary and Critical Care Medicine - Brigham and Women’s Hospital

10:25 - 10:55 AM

Morning Networking & Refreshment Break

10:55 - 12:00 PM

How AI Will Impact Respiratory Diagnosis and Treatment

A. Market Overview DOWNLOAD PRESENTATION

Presented By:
Simon Walsh, MDCofounder - The Open Source Imaging Consortium / Founder - Euclidean Diagnostics

B. Company Presentations

11:02 - 11:08 AM  | ArtiQ | Marko Topalovic, PhD, CEO DOWNLOAD PRESENTATION
11:08 - 11:14 AM  | FLUIDDA | Jan De Backer, MSc, PhD, MBA, CEO DOWNLOAD PRESENTATION
11:14 - 11:20 AM | Inscope Medical Solutions | Maggie Galloway, CEO DOWNLOAD PRESENTATION
11:20 - 11:26 AM  | Spire Health | Jonathan Palley, CEO & Co-Founder DOWNLOAD PRESENTATION
11:26 - 11:32 AM  | VIDA | Susan Wood, PhD, President & CEO DOWNLOAD PRESENTATION

C. Panel Discussion

Participants:
Chris Hogg, Chief Commercial Officer - Propeller Health
Simon Walsh, MD, Cofounder - The Open Source Imaging Consortium / Founder - Euclidean Diagnostics
George Washko, Jr., MD, Pulmonologist, Division of Pulmonary and Critical Care Medicine - Brigham and Women's Hospital
Susan Wood, PhD, President & CEO - VIDA

Moderated By:
Jan De Backer, MSc, PhD, MBA, CEO - FLUIDDA

12:00 - 12:20 PM

Innovator’s Playbook: How to Find – and Fund – Innovative Respiratory Ideas

DOWNLOAD PRESENTATION

Participants:
Mark Gelfand, Managing Partner - Coridea
Mike Pieck, Small Business Program Coordinator - NHLBI

Moderated By:
Tom Salemi, Content Director - Healthegy

12:20 - 12:30 PM

Emerging Medtech M&A and Fundraising Trends

DOWNLOAD PRESENTATION

Charles Hamilton, Director - Piper Jaffray

12:30 - 1:20 PM

Networking Lunch

1:20 - 1:55 PM

The Future of Financing Respiratory Start-Ups

DOWNLOAD PRESENTATION

Participants:
Cayce Denton, Director - Temasek
James Eadie, MD, Partner - Santé Ventures
Cecilia Gonzalo, Partner - Oberland Capital
Isai Peimer, Senior Analyst - Surveyor Capital
Jonathan Waldstreicher, MD, MBA, Principal - Apple Tree Partners

Moderated By:
Tom Salemi, Content Director - Healthegy

2:00 - 3:07 PM

What’s Next for Interventional Pulmonology

A. Market Overview

Presented By:
Momen M. Wahidi, MD, MBA, Director, Interventional Pulmonology and Bronchoscopy - Duke University Health System

B. Company Presentations

2:07 - 2:13 PM  | Gala Therapeutics | Jonathan Waldstreicher, MD, MBA, CEO DOWNLOAD PRESENTATION
2:13 - 2:19 PM | Lungpacer Medical | Doug Evans, CEO DOWNLOAD PRESENTATION
2:19 - 2:25 PM  | Nuvaira | Dennis Wahr, MD, CEO DOWNLOAD PRESENTATION
2:25 - 2:31 PM  | Optellum | Václav Potěšil, PhD, Co-Founder & CEO

C. Panel Discussion

Participants:
C. Matthew Kinsey, MD, MPH, Director, Interventional Pulmonary - University of Vermont
Jason Pesterfield, President & CEO - Veran Medical Technologies
Beran Rose, VP, Marketing & Business Development - Pulmonx
Momen M. Wahidi, MD, MBA, Director, Interventional Pulmonology and Bronchoscopy - Duke University Health System
Dennis Wahr, MD, CEO - Nuvaira

Moderated By:
Erik Folch, MD, MSc, Chief, Complex Chest Disease Center - Massachusetts General Hospital, Harvard Medical School

3:07 - 3:17 PM

Gene Therapy Overview

DOWNLOAD PRESENTATION

Presented By:
John Sheridan, Director of Research - Cystic Fibrosis Foundation

3:17 - 3:45 PM

Afternoon Networking & Refreshment Break

3:45 - 4:53 PM

What’s Emerging in IPF/ILD

A. Market Overview DOWNLOAD PRESENTATION

Presented By:
Eric White, MD, Professor of Internal Medicine, Division of Pulmonary and Critical Care Medicine - University of Michigan Medical School

B. Company Presentations

3:52 - 3:58 PM  | 4Dx | Andreas Fouras, CEO DOWNLOAD PRESENTATION
3:58 - 4:04 PM  | Bellerophon Therapeutics | Fabian Tenenbaum, CEO DOWNLOAD PRESENTATION
4:04 - 4:10 PM | Indalo Therapeutics | Karl Kossen, PhD, SVP Translational Science
4:10 - 4:16 PM  | Pliant Therapeutics | Bernard Coulie, MD, PhD, President & CEO DOWNLOAD PRESENTATION

C. Panel Discussion

Participants:
Bernard Coulie, MD, PhD, President & CEO - Pliant Therapeutics
Jonathan Goldin, MD, PhD, Professor - David Geffen School of Medicine at UCLA
Benjamin Kramer, MD, VP, Immunology & Ophthalmology, US Medical Affairs - Genentech
Eric White, MD, Professor of Internal Medicine, Division of Pulmonary and Critical Care Medicine - University of Michigan Medical School

Moderated By:
Craig S. Conoscenti, MD, FCCP, ATSF, Medical Expert, Interstitial Lung Disease - Boehringer Ingelheim Pharmaceuticals

4:53 - 5:00 PM

Closing Remarks

Cecilia Gonzalo, Partner - Oberland Capital

5:00 - 6:00 PM

Networking Reception